Zacksenhaus E - Search Results

1

Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.

Liu JC, Deng T, Lehal RS, Kim J, Zacksenhaus E. Liu JC, et al. Among authors: zacksenhaus e. Cancer Res. 2007 Sep 15;67(18):8671-81. doi: 10.1158/0008-5472.CAN-07-1486. Cancer Res. 2007. PMID: 17875707

2

Inactivation of the retinoblastoma tumor suppressor induces apoptosis protease-activating factor-1 dependent and independent apoptotic pathways during embryogenesis.

Guo Z, Yikang S, Yoshida H, Mak TW, Zacksenhaus E. Guo Z, et al. Among authors: zacksenhaus e. Cancer Res. 2001 Dec 1;61(23):8395-400. Cancer Res. 2001. PMID: 11731416

3

Preferential killing of breast tumor initiating cells by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine/tesmilifene.

Deng T, Liu JC, Pritchard KI, Eisen A, Zacksenhaus E. Deng T, et al. Among authors: zacksenhaus e. Clin Cancer Res. 2009 Jan 1;15(1):119-30. doi: 10.1158/1078-0432.CCR-08-1708. Clin Cancer Res. 2009. PMID: 19118039

4

Cyclins, Cdks, E2f, Skp2, and more at the first international RB Tumor Suppressor Meeting.

Bremner R, Zacksenhaus E. Bremner R, et al. Among authors: zacksenhaus e. Cancer Res. 2010 Aug 1;70(15):6114-8. doi: 10.1158/0008-5472.CAN-10-0358. Epub 2010 Jul 7. Cancer Res. 2010. PMID: 20610631

5

Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.

Jiang Z, Deng T, Jones R, Li H, Herschkowitz JI, Liu JC, Weigman VJ, Tsao MS, Lane TF, Perou CM, Zacksenhaus E. Jiang Z, et al. Among authors: zacksenhaus e. J Clin Invest. 2010 Sep;120(9):3296-309. doi: 10.1172/JCI41490. Epub 2010 Aug 2. J Clin Invest. 2010. PMID: 20679727 Free PMC article.

6

Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formation.

Adams JR, Xu K, Liu JC, Agamez NM, Loch AJ, Wong RG, Wang W, Wright KL, Lane TF, Zacksenhaus E, Egan SE. Adams JR, et al. Among authors: zacksenhaus e. Cancer Res. 2011 Apr 1;71(7):2706-17. doi: 10.1158/0008-5472.CAN-10-0738. Epub 2011 Feb 15. Cancer Res. 2011. PMID: 21324922

7

RB1 and p53 at the crossroad of EMT and triple-negative breast cancer.

Jiang Z, Jones R, Liu JC, Deng T, Robinson T, Chung PE, Wang S, Herschkowitz JI, Egan SE, Perou CM, Zacksenhaus E. Jiang Z, et al. Among authors: zacksenhaus e. Cell Cycle. 2011 May 15;10(10):1563-70. doi: 10.4161/cc.10.10.15703. Epub 2011 May 15. Cell Cycle. 2011. PMID: 21502814 Review.

8

Elevated PI3K signaling drives multiple breast cancer subtypes.

Adams JR, Schachter NF, Liu JC, Zacksenhaus E, Egan SE. Adams JR, et al. Among authors: zacksenhaus e. Oncotarget. 2011 Jun;2(6):435-47. doi: 10.18632/oncotarget.285. Oncotarget. 2011. PMID: 21646685 Free PMC article. Review.

9

Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2+:ERα- breast cancer.

Liu JC, Voisin V, Bader GD, Deng T, Pusztai L, Symmans WF, Esteva FJ, Egan SE, Zacksenhaus E. Liu JC, et al. Among authors: zacksenhaus e. Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):5832-7. doi: 10.1073/pnas.1201105109. Epub 2012 Mar 28. Proc Natl Acad Sci U S A. 2012. PMID: 22460789 Free PMC article.

10

Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer.

Xu K, Usary J, Kousis PC, Prat A, Wang DY, Adams JR, Wang W, Loch AJ, Deng T, Zhao W, Cardiff RD, Yoon K, Gaiano N, Ling V, Beyene J, Zacksenhaus E, Gridley T, Leong WL, Guidos CJ, Perou CM, Egan SE. Xu K, et al. Among authors: zacksenhaus e. Cancer Cell. 2012 May 15;21(5):626-641. doi: 10.1016/j.ccr.2012.03.041. Cancer Cell. 2012. PMID: 22624713 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters